Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -163.39% is 169% below its 2-year average of -60.67%, near the low end of its 2-year range (-163.39%–1.79%).
As of the fiscal period ended Wednesday, December 31, 2025. 77.80% below its 12-month average of -91.89%.
Annual fiscal-year return on invested capital; no daily interpolation. Historical series through 2025-12-31.
RETURN ON INVESTED CAPITAL (ROIC)
-163.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-91.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-77.80%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-358.38%
vs the sector median at left
SL Science Holding Ltd
Market Cap
$853.20M
Return on Invested Capital (ROIC)
-163.39%
TTM Avg
-91.89%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$855.28M
Return on Invested Capital (ROIC)
-7.88%
TTM Avg
-13.88%
3Y Avg
-23.54%
5Y Avg
-23.72%
Market Cap
$849.50M
Return on Invested Capital (ROIC)
-23.80%
TTM Avg
-58.06%
3Y Avg
-39.20%
5Y Avg
-32.57%
Market Cap
$861.64M
Return on Invested Capital (ROIC)
18.72%
TTM Avg
24.77%
3Y Avg
-14.92%
5Y Avg
-18.89%
Market Cap
$843.58M
Return on Invested Capital (ROIC)
-16.05%
TTM Avg
-26.23%
3Y Avg
-9.21%
5Y Avg
8.44%
Market Cap
$841.08M
Return on Invested Capital (ROIC)
-31.17%
TTM Avg
-29.64%
3Y Avg
-85.48%
5Y Avg
-85.48%
Market Cap
$839.01M
Return on Invested Capital (ROIC)
-26.54%
TTM Avg
-38.64%
3Y Avg
-38.64%
5Y Avg
-38.64%
Market Cap
$837.93M
Return on Invested Capital (ROIC)
-94.76%
TTM Avg
-114.06%
3Y Avg
-144.57%
5Y Avg
-144.57%
Market Cap
$873.28M
Return on Invested Capital (ROIC)
-25.25%
TTM Avg
-75.69%
3Y Avg
-67.13%
5Y Avg
-61.15%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SL Science Holding Ltd (SLBT) | $853.20M | -163.39% | -91.89% | N/A | N/A |
| SI-BONE, Inc. (SIBN)vs › | $855.28M | -7.88% | -13.88% | -23.54% | -23.72% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $849.50M | -23.80% | -58.06% | -39.20% | -32.57% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $861.64M | 18.72% | 24.77% | -14.92% | -18.89% |
| QuidelOrtho Corporation (QDEL)vs › | $843.58M | -16.05% | -26.23% | -9.21% | 8.44% |
| Beta Bionics, Inc. (BBNX)vs › | $841.08M | -31.17% | -29.64% | -85.48% | -85.48% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $839.01M | -26.54% | -38.64% | -38.64% | -38.64% |
| Alumis Inc. (ALMS)vs › | $837.93M | -94.76% | -114.06% | -144.57% | -144.57% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $873.28M | -25.25% | -75.69% | -67.13% | -61.15% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $836.41M | -28.69% | -21.44% | -33.52% | -49.04% |
ROIC
-163.4%
ROE
-167.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -163.39% |
| 2024-12-31 | -20.40% |
| 2023-12-31 | 1.79% |
